Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) is a novel therapeutic target for diabetic complications.
about
Coadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic EffectsEffect of plant extracts on H2O2-induced inflammatory gene expression in macrophages.Therapeutic potential of pterostilbene against pancreatic beta-cell apoptosis mediated through Nrf2.Activation of Nrf2 signaling by natural products-can it alleviate diabetes?Long noncoding RNA ENSRNOG00000037522 is involved in the podocyte epithelial‑mesenchymal transition in diabetic rats.Nrf2 as molecular target for polyphenols: A novel therapeutic strategy in diabetic retinopathy.
P2860
Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) is a novel therapeutic target for diabetic complications.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Nuclear factor (erythroid-deri ...... et for diabetic complications.
@en
type
label
Nuclear factor (erythroid-deri ...... et for diabetic complications.
@en
prefLabel
Nuclear factor (erythroid-deri ...... et for diabetic complications.
@en
P2093
P2860
P356
P1476
Nuclear factor (erythroid-deri ...... et for diabetic complications.
@en
P2093
Lining Miao
Xiaohong Xu
Yangwei Wang
Yingchun Cui
P2860
P356
10.1177/0300060513477004
P577
2013-01-24T00:00:00Z